Medication Regimen for ADHD and ASD with Comorbid Mood Disorder and Anxiety

Initial Treatment Strategy

The American Academy of Child and Adolescent Psychiatry recommends starting atomoxetine at 40mg daily for adults, titrating gradually over 2-4 weeks to a target dose of 80-100mg daily, as it addresses ADHD symptoms while providing "around-the-clock" effects without the rebound/crash of stimulants and can simultaneously reduce anxiety symptoms 1
Full therapeutic effect of atomoxetine requires 4-6 weeks at therapeutic dose, and effectiveness should be assessed after 6-8 weeks at therapeutic dose 1
Monitor for decreased appetite and weight loss as common side effects of atomoxetine 1

Stimulants should be avoided initially in this population due to concerns about exacerbating mood instability and emotional reactivity, as stated by the American Academy of Child and Adolescent Psychiatry 1
The American Academy of Child and Adolescent Psychiatry notes that while stimulants are effective for ADHD with comorbid anxiety in typical populations, the addition of ASD and mood disorder changes this risk-benefit calculation 2, 3

If the mood disorder presents with severe symptoms, treat the mood disorder first before addressing ADHD, as recommended by the American Academy of Child and Adolescent Psychiatry 2, 3
Once mood is stabilized, reassess ADHD symptoms and then initiate atomoxetine as described above 3, 1

If atomoxetine provides insufficient response, consider alpha-2 agonists (guanfacine extended-release or clonidine extended-release) as they address both ADHD symptoms and emotional dysregulation, according to the American Academy of Child and Adolescent Psychiatry 1
Bupropion is another alternative, though evidence is stronger in adults without ASD, as noted by the American Academy of Child and Adolescent Psychiatry 1

In ASD patients with significant mood instability, irritability, or aggression, mood stabilizers (lithium or divalproex sodium) should be considered, particularly if symptoms persist despite ADHD treatment, as recommended by the American Academy of Child and Adolescent Psychiatry 3
Dialectical Behavior Therapy (DBT) should be incorporated alongside pharmacotherapy, targeting mindfulness, distress tolerance, interpersonal skills, and emotion regulation, according to the American Academy of Child and Adolescent Psychiatry 1
Cognitive behavioral therapy or interpersonal therapy should be considered if mood symptoms remain severe despite medication, as stated by the American Academy of Child and Adolescent Psychiatry 2, 3

Do not use stimulants as first-line in this population due to risk of exacerbating mood instability and emotional dysregulation in ASD with mood disorder, as warned by the American Academy of Child and Adolescent Psychiatry 1
Do not treat ADHD before stabilizing severe mood symptoms if psychosis, suicidality, or severe neurovegetative signs are present, as cautioned by the American Academy of Child and Adolescent Psychiatry 2, 3
Do not expect immediate results with atomoxetine—allow full 6-8 weeks at therapeutic dose before declaring treatment failure, as advised by the American Academy of Child and Adolescent Psychiatry 1